Green Mountain Development Corp. (GMND) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerGreen Mountain Development Corp. (GMND) trades at $0.0001. Green Mountain Development Corp. focuses on providing project development services and distributing licensed products in the energy, agricultural, and environmental sectors. Sector: Industrials.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for GMND: GMND does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Green Mountain Development Corp. (GMND) Industrial Operations Profile
Green Mountain Development Corp. offers project development services and distributes licensed Bio-Miracle microbial blends, targeting the energy, agricultural, and environmental sectors. With a focus on assisting clients in project due diligence and providing solutions for agricultural enhancement and waste management, the company operates in a competitive landscape with varied environmental solutions.
What Is the Investment Thesis for GMND?
Green Mountain Development Corp. presents a speculative investment opportunity within the waste management and environmental solutions sector. The company's diverse product line, including Bio-Miracle microbial blends, targets multiple high-growth areas such as agriculture and environmental remediation. However, the company's negative profit margin of -491.6% and a market capitalization of $0.00B indicate significant financial challenges. Growth catalysts include potential expansion of Bio-Miracle product distribution and successful development of new life science products. Key value drivers would be achieving profitability and securing significant project development contracts. Investors should carefully consider the risks associated with OTC-listed companies, including limited liquidity and disclosure requirements, before investing.
Based on FMP financials and quantitative analysis
GMND Key Highlights
Market capitalization of $0.00B, indicating a micro-cap company with high growth potential but also significant risk.
- Negative P/E ratio of -0.00, reflecting the company's current lack of profitability.
- Profit margin of -491.6%, highlighting substantial losses relative to revenue.
- Gross margin of 0.4%, indicating very limited profitability from sales after accounting for the cost of goods sold.
- Beta of -8.63, suggesting an inverse correlation with the market, but potentially unreliable due to the company's financial instability.
Who Are GMND's Competitors?
What Are GMND's Key Strengths?
Diverse product line of Bio-Miracle microbial blends.
- Focus on sustainable and environmentally friendly solutions.
- Project development services for capital providers and technology operators.
- Proprietary formulations for remediation, waste management, and agricultural enhancement.
What Are GMND's Weaknesses?
Negative profit margin and low gross margin.
- Limited market capitalization and financial resources.
- Dependence on distribution partnerships for product sales.
- OTC listing with associated risks and limited liquidity.
What Are the Key Risks for GMND?
Limited access to capital for expansion and research.
- Competition from larger waste management and environmental services companies.
- Regulatory changes impacting environmental solutions.
- Negative profit margin and low gross margin.
- OTC listing with associated risks and limited liquidity.
What Are GMND's Competitive Advantages?
- Specialized Bio-Miracle microbial blends offer unique solutions for agriculture and waste management.
- Established relationships with capital providers and technology operators.
- Proprietary formulations for remediation, waste management, and agricultural enhancement.
- Focus on sustainable and environmentally friendly solutions.
What Does GMND Do?
Green Mountain Development Corp., based in Carlsbad, California, provides project development services for capital providers and technology operators, focusing on the energy, agricultural, and environmental sectors. The company assists clients with preliminary development work, including project due diligence, investor presentations, identification of project capital sources and technology vendors, and negotiation of joint venture agreements. A key aspect of their business is the distribution of Bio-Miracle microbial blends, which are used for agricultural growth enhancement, composting acceleration, pond and lake water treatment, hydrocarbon reduction in soil and water, and animal and green waste treatment. The Bio-Miracle product lines include Remediline remediation products, featuring SPILL KILL PRO for oil spill cleanup and SIZZLE CLEAN for parts cleaning. Wasteline waste management products include MANURE KING for manure control and SPARKLE CLEAN for septic and cesspool cleanup. Bi-Agra agricultural products, such as Bi-Agra-100, Bi-Agra-200, TOO TALL TOMATOES, and COMPOST PAL, are designed to improve plant health, size, and yield. Green Mountain Development Corp. also engages in the research, development, and production of life science products, further diversifying its offerings within the environmental and agricultural sectors. The company's operational focus is on providing comprehensive solutions and support to clients across various stages of project development and product distribution.
What Products and Services Does GMND Offer?
- Provides project development services for capital providers and technology operators.
- Distributes licensed products related to the energy sector.
- Distributes licensed products related to the agricultural sector.
- Distributes licensed products related to the environmental sector.
- Assists clients with project due diligence.
- Distributes Bio-Miracle microbial blends for agricultural growth enhancement.
- Offers solutions for composting acceleration and water treatment.
- Focuses on research, development, and production of life science products.
How Does GMND Make Money?
- Generates revenue through project development service fees.
- Revenue from distribution of Bio-Miracle microbial blends.
- Sales of Remediline remediation products (SPILL KILL PRO, SIZZLE CLEAN).
- Sales of Wasteline waste management products (MANURE KING, SPARKLE CLEAN).
- Sales of Bi-Agra agricultural products (Bi-Agra-100, Bi-Agra-200, TOO TALL TOMATOES, COMPOST PAL).
What Industry Does GMND Operate In?
Green Mountain Development Corp. operates within the waste management and environmental services industry, a sector experiencing increased demand due to growing environmental concerns and stricter regulations. The market includes established players offering comprehensive waste management solutions and smaller, specialized companies focusing on niche areas like microbial remediation. Green Mountain Development Corp.'s focus on Bio-Miracle microbial blends positions it within the specialized segment of biological solutions for agriculture and waste treatment. The company faces competition from both larger waste management firms and other specialized environmental solution providers.
Who Are GMND's Key Customers?
- Capital providers investing in energy, agricultural, and environmental projects.
- Technology operators seeking project development support.
- Farmers and agricultural businesses using Bi-Agra products.
- Businesses and municipalities requiring waste management solutions.
- Organizations needing environmental remediation products.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Green Mountain Development Corp. operates in the Industrials sector. It is headquartered in Carlsbad, US. The company is led by CEO Robert C. Brehm. GMND has traded publicly since 2009.
GMND Financials
GMND Latest News
No recent news available for GMND.
GMND Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for GMND.
Price Targets
Wall Street price target analysis for GMND.
GMND MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for GMND; grades run from A+ (80-100) to F (below 30).
Who Are GMND's Competitors?
Leadership: Robert C. Brehm
CEO
Robert C. Brehm serves as the CEO of Green Mountain Development Corp. His background includes experience in project development and management within the energy, agricultural, and environmental sectors. He has been involved in identifying project capital sources, negotiating joint venture agreements, and overseeing the development of investor presentations. His expertise lies in bridging the gap between technology operators and capital providers to facilitate project execution.
Track Record: Under Robert C. Brehm's leadership, Green Mountain Development Corp. has focused on expanding its Bio-Miracle product line and providing project development services. Key milestones include the introduction of new microbial blends for agricultural enhancement and waste management. His strategic decisions have aimed at positioning the company as a provider of sustainable solutions within the environmental sector.
GMND OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Green Mountain Development Corp. may not meet minimum financial standards or have chosen not to provide current information to OTC Markets Group. Companies in this tier often have limited or no financial reporting requirements, making it difficult for investors to assess their financial health and operational performance. This tier is distinct from the NYSE or NASDAQ, which have stringent listing requirements related to market capitalization, trading volume, and financial reporting.
- OTC Tier: OTC Other
- Limited financial disclosure increases the risk of investing in GMND.
- Low trading volume and wide bid-ask spreads can lead to significant price volatility.
- OTC Other tier status indicates potential financial instability or lack of regulatory compliance.
- The company's small market capitalization makes it susceptible to manipulation.
- Lack of analyst coverage and institutional interest increases investment risk.
- Verify the company's financial statements and disclosure status.
- Assess the company's management team and their track record.
- Evaluate the company's business model and competitive landscape.
- Review the company's legal and regulatory compliance.
- Analyze the company's capital structure and debt obligations.
- Check for any history of fraud or misconduct.
- Understand the risks associated with investing in OTC stocks.
- The company's focus on sustainable and environmentally friendly solutions.
- Distribution of Bio-Miracle microbial blends for various applications.
- Project development services for capital providers and technology operators.
- CEO Robert C. Brehm's experience in project development and management.
GMND Industrials Stock FAQ
What do analysts say about GMND stock?
Currently, there is limited to no analyst coverage for Green Mountain Development Corp. due to its OTC listing and small market capitalization.
What are the main risks for GMND?
The main risks for Green Mountain Development Corp. include its negative profit margin, low gross margin, and limited market capitalization.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC market data may be limited or delayed.